Cardiac Rhythm Management (CRM) Devices: Market Research Report

October 2011 | 375 pages | ID: CE0D2BFD3AAEN
Global Industry Analysts, Inc

Abstracts

This report analyzes the worldwide markets for Cardiac Rhythm Management (CRM) Devices in US$ Million by the following Product Segments: Implantable Cardioverter Defibrillators (ICD), Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) devices.

The report provides separate comprehensive analytics for the US, Europe, Asia-Pacific, and Rest of World.

Annual estimates and forecasts are provided for the period 2009 through 2017.

A six-year historic analysis is also provided for these markets.

The report profiles 48 companies including many key and niche players such as Bard Electrophysiology, Biosense Webster, Inc., Biotronik GMBH & Co. KG, Boston Scientific Corporation, Medtronic, Inc., Medtronic CryoCath LP, Vitatron Nederland BV, Philips Healthcare, St. Jude Medical, Inc., and Sorin Group.

Market data and analytics are derived from primary and secondary research.

Company profiles are mostly extracted from URL research and reported select online sources.

Contents

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Implantable Cardioverter Defibrillators (ICD)
Pacemaker
External Defibrillators
Electrophysiology (EP) Catheterization, Mapping, and Ablation (CMA)

2. INDUSTRY OVERVIEW

A Prelude
Cardiac Rhythm Management Devices - An Outlook
Implantable Cardioverter Defibrillators
Pacemakers
External Defibrillators
EP Catheterization, Mapping, & Ablation (CMA)
Market Structure

Table 1. World Market for Cardiac Rhythm Management (CRM) Devices (2010): Percentage Breakdown of Annual Revenues by Companies (includes corresponding Graph/Chart)

Table 2. World Market for High Power CRM Devices (2010): Percentage Breakdown of Annual Revenues by Companies. (includes corresponding Graph/Chart)

Table 3. World Market for Low Power CRM Devices (2010): Percentage Breakdown of Annual Revenues by Companies(includes corresponding Graph/Chart)

Table 4. World Market for Implantable Cardioverter Defibrillator (2010): Percentage Breakdown of Annual Revenues by Companies (includes corresponding Graph/Chart)

Table 5. World External Defibrillators Market (2010): Percentage Market Share Breakdown of Leading Players – Medtronic, Philips and Others (includes corresponding Graph/Chart) (includes corresponding Graph/Chart)

Table 6. World Market for Advanced Cardiac Resynchronization Therapy (CRT) Devices (2010): Percentage Market Share Breakdown of Leading Players – Medtronic, Boston Scientific (Guidant), St. Jude Medical, and Others (includes corresponding Graph/Chart)

3. TRENDS & ISSUES

SSS and AV Block Incidence Triggers Demand for Pacemakers ……
Infamous Product Recalls Throw Growth Off-track
Market Shapes Up After the Recall Shock
Regulatory Riders Knit to Ensure Greater Device Reliability
Growing Proportion of Obese Population: A Major Demographic Driver
Replacements to Drive the Growth of ICDs
Developments in Energy-Based Therapies Augur Well for Cardiac Ablation Treatments
Expanding Applications Lend Traction to Growth
Prices of Cardiac Pacemakers Soften
Heart Patients Using ICD, Enjoy Satisfactory Quality Life
Pacemakers Ensure Effective Management of Non-Systolic Heart Failures
CRT: An Effective Treatment for Bradycardia, Tachycardia & Fibrillation
ICDs in Pediatric Care Shows Promise
Emerging Therapies for the Treatment of Atrial Fibrillation
New Generation CRM Devices Feature Superior Benefits
MRI-Compatible Pacemakers & ICDs
Resistance Against Electronic Interferences
Confusion Over the Use of CRM Devices Threaten Perceived Effectiveness
Breathing Disorders in Patients Implanted with Pacemakers: A Cause for Concern
Approval of Untested Pacemaker Connectors Raises Eyebrows
ICD Lead Failure Demands Immediate Attention
Pacemaker Hacking Has the Industry Up by Its Ears
Pacemakers Face Stiff Competition from CRT-D Devices
ICDs More Prone to Malfunction than Pacemakers
Conclusion
Technology Innovation: A Futuristic Rumination
The Heart to Power CRM Devices: The Future of CRM Therapies
Genetic Advances to Yield Replacement for Pacemakers
Ablation Technology Undergoing Innovations
Vein Ablation Catheter Proves Successful in Cases of Paroxysmal Atrial Fibrillation
Ablation Therapy Useful in Treating Persistent/ Permanent Atrial Fibrillation (PPAF)
Magnetic Navigation: An Innovation in Catheter Ablation
New Force-Sensing Ablation Catheter Aims to Aid Physician Decision Making
Pricing & Reimbursements: Critical Determinants of Growth
New Guidelines Issued for Safe Management of CRM Devices in the US and Europe

4. PRODUCT OVERVIEW

Sudden Cardiac Arrest: A Leading Cause of Death
Cardiac Rhythm Management (CRM): A Definition
Implantable Cardioverter Defibrillators (ICDs)
Surgical Implantation of ICDs: The Procedure
ICDs – The Benefits
Types of ICDs
ICDs: An Evolution Scan
Complications Associated With ICD Usage
CRT-D – A New Therapeutic Device
Pacemakers
Surgical Implantation of Pacemakers: The Procedure
Types of Pacemakers
Methods of Pacing
Fixed Rate Pacemakers
Demand Pacemakers
Rate-Responsive Pacemaker
Pacemakers: An Evolution Scan
Complications Associated with Pacemakers
Advent of CRT-P
Electrophysiology (EP) Catheterization, Mapping, and Ablation (CMA)
The Ablation Procedure
External Defibrillators
Types of AEDs
Cardiac Rhythm Disorders: A Brief Review
Cardiac Arrhythmias
Classification of Cardiac Arrhythmias
Bradycardia
Tachycardia
Atrial Fibrillation
Heart Blocks
Syncope
Sick Sinus Syndrome
Cardiomyopathy

5. PRODUCT APPROVALS/INTRODUCTIONS

Boston Scientific Unveils CRM Connector System
Biosense Catheter Receives FDA Marketing Approval
St. Jude Medical Secures Approval for Atlas II ICD from Japan
Zoll Medical Defibrillators Receive FDA Clearance
St. Jude Medical Receives CE Mark for Integrated Irrigation Pump and Ablation Generator
AtriCure Secures FDA 510(k) Approval for Coolrail Device
Hansen Medical Gains FDA Approval for CoHesion™ Module
St. Jude Medical Obtains CE Mark and FDA Approval for HIFU Surgical Ablation Solutions
Biosense Releases NAVISTAR® RMT THERMOCOOL® Catheter
Atricure Unveils The ORLab™
Cardima Receives SFDA Approval to Market INTELLITEMP® in China
ZOLL Obtains 510K Clearance to Sell and Market Zoll R Series Code-Ready Defibrillator
ST. Jude Medical Obtains FDA and CE Mark Approval for New Epicor LP Cardiac Ablation System
Cardima Obtains Approval for Marketing Surgical Ablation System in Thailand
ATS Medical Introduces First CryoMaze Surgical Ablation Clamp
CardioNet Unveils New Reporting Package for Atrial Fibrillation Treatment
Boston Scientific Defibrillator Receives CE Mark Approval
TyRx Introduces New Anti-bacterial Envelope, AIGISRX™ ICD
St. Jude Medical Receives Approval from Japanese MHLW
Boston Scientific Secures FDA Approval for CRM Solutions
Sorin Group Develops New-Generation CRT-D Implants
BSC Secures CE Mark Approval for ALTRUA Pacemakers
Medtronic Secures FDA Approval for New Vision 3D Devices
Medtronic Obtains FDA Approval for Software Update
St. Jude Medical Obtains FDA Approval for SJM Cardiac Monitor
Boston Scientific Obtains Approval For Cognis CRT-D And Teligen ICD
FDA Approves Medtronic’s Medtronic Sprint Quattro Secure® S Lead
Medtronic Obtains CE Mark Approval for Pacemaker and Pacing Leads
St. Jude Medical Obtains Japanese Approval for Victory® Pacemakers Family
Sorin Group Obtains Approval For Isoline Defibrillation Leads In Japan
BSC Secures FDA Approval for New ALTRUA Pacemakers
St. Jude Medical Obtains Approval for Durata Defibrillation Lead
St. Jude Medical Obtains Japanese Approval for Durata Defibrillation Lead
St. Jude Medical Obtains Japanese Approval for Victory Family of Pacemakers
Sorin Group Gains FDA Approval for OVATIO™
Sorin SpA Gains FDA Approval for REPLY
Medtronic Receives Approval for Lead Integrity Alert™
Physio-Control Gains FDA Approval for LIFEPAK® 20e Defibrillator/Monitor
TyRx Introduces New Anti-Bacterial Envelope, AIGISRX™ ICD
LifeWatch Introduces Next-Generation Monitor, LifeStar ACT III Platinum
eCardio Launches eVolution, New Cardiac Monitoring System
Philips Introduces PageWriter TC70 Cardiograph
Sorin Group Announces Commercial Release and First Implant of PARADYM™ CRT 8750
St. Jude Medical Introduces QuickOpt® Timing Cycle Optimization in CRT-D
Cardiac Science Unveils Simple Electronic Reporting System
Mennen Medical Introduces VitaLogik® 4000 Line
BIOTRONIK Releases CRT-P in US Market
Vermed Releases Defibrillation Pads Series and Universal Connector System
St. Jude Releases Reflexion Spiral X™ in US

6. RECENT INDUSTRY ACTIVITY

Novation Partners St. Jude Medical for CRM Products
Medtronic Sets Up Production Unit in Singapore
Novation Collaborates with BIOTRONIK
Boston Scientific Inks Agreement with Fukuda Denshi
Creganna Closes Tactx Medical Acquisition
Medtronic Takes Over Ablation Frontiers
Sorin Enters into Agreement with Orange Business Services
Philips Signs a Deal with Bard Electrophysiology
Boston Scientific Bags CRM Contract from Dept. of Veterans Affairs
Medtronic and Boston Scientific Inks Agreement to End IP Disputes
St Jude Medical to Invest in Penang
Cardima Enters into a Distribution Agreement with Peerless Medical
Cardiac Science Enters into an Alliance with Boy Scouts of America
Cardima Enters into a New Strategic Surgical Alliance with Biocore
Cardima Enters into a New Strategic Marketing Alliance with On-X Life Technologies
Welch Allyn and ZOLL Medical Corporation Collaborate
Cardima Selects Dot Medical to Distribute Its EP Products in the UK
Royal Philips to Guide ‘euHeart’ Project
Target Center Acquires HeartSine® Defibrillators
St Jude Medical Acquires EP MedSystems
St. Jude Takes Over Radi Medical AB
Medrad to Acquire Possis
Phoenix Acquires Stake in Possis
Biotronik Acquires VascoMed
Medtronic Takes Over CryoCath Technologies
Boston Scientific Takes Over CryoCor
St. Jude Completes Acquisition of MediGuide
Greatbatch Enters Into A Strategic Partnership With Issys
Sorin Group Inks Collaborative Agreement with Greatbatch
Philips Enters into MOU with King’s College London on Research Collaboration
Welch Allyn Collaborates with ZOLL Medical Corporation
ZOLL and HealthTrust Sign Purchasing Deal
ZOLL Inks Multi-Year Agreement with Masimo
First Responder Wins Contract from Harvard School of Public Health
Beijing Airport Group to Deploy ZOLL AED Plus Solutions
STH NHS Trust to Deploy New R Series BLS Solutions of ZOLL
Major EMS Centers in China Deploys ZOLL M Series Defibrillator
DRF to Deploy corpuls3 Heart Defibrillators
Riedel & Schulz and GS Elektromed Distributes 8 corpuls3 Medical Units
Trivitron Inks Marketing And Distribution Agreement With Boston Scientific
CardioComm Signs Licensing Agreement with GE Healthcare
Cambridge Heart Licenses Technology for Implantable Devices
Synovis Life Technologies to Divest Interventional Business
Boston Scientific Divests Cardiac Surgery And Vascular Surgery Businesses
Sorin Group Sells Its Vascular Therapy Business to CIDl

7. FOCUS ON SELECT PLAYERS

Bard Electrophysiology (US)
Biosense Webster, Inc. (US)
Biotronik GMBH & Co. KG (Germany)
Boston Scientific Corporation (US)
Medtronic, Inc. (US)
Medtronic CryoCath LP (US)
Vitatron Nederland BV (Netherlands)
Philips Healthcare (The Netherlands)
St. Jude Medical, Inc. (US)
Sorin Group (Italy)

8. GLOBAL MARKET PERSPECTIVE

Table 7. World Recent Past, Current & Future Analysis for Cardiac Rhythm Management Devices by Geographic Region – US, Europe, Asia-Pacific and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)

Table 8. World Historic Review for Cardiac Rhythm Management Devices by Geographic Region – US, Europe, Asia-Pacific and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)

Table 9. World 15-Year Perspective for Cardiac Rhythm Management Devices by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe, Asia-Pacific and Rest of World Markets for Years 2003, 2010 & 2017 (includes corresponding Graph/Chart)

Table 10. World Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators by Geographic Region – US, Europe, Asia-Pacific and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)

Table 11. World Historic Review for Implantable Cardioverter Defibrillators by Geographic Region – US, Europe, Asia-Pacific and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)

Table 12. World 15-Year Perspective for Implantable Cardioverter Defibrillators by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe, Asia-Pacific and Rest of World Markets) for Years 2003, 2010 & 2017 (includes corresponding Graph/Chart)

Table 13. World Recent Past, Current & Future Analysis for Pacemakers by Geographic Region – US, Europe, Asia- Pacific and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)

Table 14. World Historic Review for Pacemakers by Geographic Region – US, Europe, Asia-Pacific and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)

Table 15. World 15-Year Perspective for Pacemakers by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe, Asia-Pacific and Rest of World Markets) for Years 2003, 2010 & 2017 (includes corresponding Graph/Chart)

Table 16. World Recent Past, Current & Future Analysis for External Defibrillators by Geographic Region – US, Europe, Asia-Pacific and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)

Table 17. World Historic Review for External Defibrillators by Geographic Region – US, Europe, Asia-Pacific and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)

Table 18. World 15-Year Perspective for External Defibrillators by Geographic Region – Percentage Breakdown of Dollar Sales for US, Europe, Asia-Pacific and Rest of World Markets) for Years 2003, 2010 & 2017 (includes corresponding Graph/Chart)

Table 19. World Recent Past, Current & Future Analysis for EP Catheterization, Mapping, & Ablation (CMA) by Geographic Region – US, Europe, Asia-Pacific and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)

Table 20. World Historic Review for EP Catheterization, Mapping, & Ablation (CMA)by Geographic Region – US, Europe, Asia-Pacific and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)

Table 21. World 15-Year Perspective for EP Catheterization, Mapping, & Ablation (CMA) by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe, Asia-Pacific and Rest of World Markets) for Years 2003, 2010 & 2017 (includes corresponding Graph/Chart)

9. THE UNITED STATES

A. MARKET ANALYSIS

Outlook
Market Overview
Demand for Automated External Defibrillators Shoots Up in the US
Market Share Statistics

Table 22. US Market for (ICD) Implantable Cardioverter Defibrillators (2011): Percentage Breakdown of Annual Revenues by Companies (includes corresponding Graph/Chart)

Table 23. US Market for Core Pacemakers & CRT-P (2010): Percentage Breakdown of Annual Revenues by Companies (includes corresponding Graph/Chart)

Cardiovascular Disease Incidence Statistics

Table 24. Cardiovascular Diseases in US (2010): Percentage Breakdown of Total Economic Cost Incurred for Treatment by Disease Type (includes corresponding Graph/Chart)

Table 25. Cardiovascular Diseases in US (2010): Percentage Breakdown of Total Economic Cost Incurred for Treatment by Type of Expenditure (includes corresponding Graph/Chart)

Table 26. Cardiovascular Diseases (CvD) in US (2010): Incidence of CvDs in Adult Population Segregated by Age and Gender (includes corresponding Graph/Chart)

Table 27. Cardiovascular Diseases (CvD) in the US (2010): Percentage Breakdown of Deaths by Type of Causal CvD (includes corresponding Graph/Chart)

B. MARKET ANALYTICS

Table 28. US Recent Past, Current & Future Analysis for Cardiac Rhythm Management Devices by Product Segment – Implantable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)

Table 29. US Historic Review for Cardiac Rhythm Management Devices by Product Segment – Implantable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)

Table 30. US 15-Year Perspective for Cardiac Rhythm Management Devices by Product Segment - Percentage Breakdown of Dollar Sales for Implantable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) for Years 2003, 2010 & 2017 (includes corresponding Graph/Chart)

10. EUROPE

A. MARKET ANALYSIS

Outlook
Major Market Trends
Flourishing Market for CRM Market in Western Europe
Bright Future for CRM Devices Industry
Highly Competitive External Defibrillators Market Paves Way for Consolidations
Strong Demand for Implantable Cardiac Defibrillators in UK

B. MARKET ANALYTICS

Table 31. European Recent Past, Current & Future Analysis for Cardiac Rhythm Management Devices by Product Segment – Implantable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)

Table 32. European Historic Review for Cardiac Rhythm Management Devices by Product Segment – Implantable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)

Table 33. European 15-Year Perspective for Cardiac Rhythm Management Devices by Product Segment - Percentage Breakdown of Dollar Sales for Implantable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) for Years 2003, 2010 & 2017 (includes corresponding Graph/Chart)

11. ASIA PACIFIC

A. MARKET ANALYSIS

Outlook
Major Market Trends
Increasing Heart Diseases Spur Demand for CRM Devices
Chinese CRM Market to Witness Robust Growth

B. MARKET ANALYTICS

Table 34. Asia Pacific Recent Past, Current & Future Analysis for Cardiac Rhythm Management Devices by Product Segment – Implantable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)

Table 35. Asia Pacific Historic Review for Cardiac Rhythm Management Devices by Product Segment – Implantable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)

Table 36. Asia Pacific 15-Year Perspective for Cardiac Rhythm Management Devices by Product Segment - Percentage Breakdown of Dollar Sales for Implantable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) for Years 2003, 2010 & 2017 (includes corresponding Graph/Chart)

12. REST OF WORLD

A. MARKET ANALYSIS

Outlook
Market Share Statistics

Table 37. Implantable Cardioverter Defibrillator (ICD) Market in EMEA, Asia, & South America (2010): Percentage Market Share Breakdown of Leading Players – Medtronic, Boston Scientific (Guidant), St Jude Medical, and Others (includes corresponding Graph/Chart)

Table 38. Core Pacemakers & CRT-P Market in EMEA, Asia, & South America (2010): Percentage Market Share Breakdown of Leading Players – Medtronic, St. Jude, Boston Scientific and Others (includes corresponding Graph/Chart)

B. MARKET ANALYTICS

Table 39. Rest of World Recent Past, Current & Future Analysis for Cardiac Rhythm Management Devices by Product Segment – Implantable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)

Table 40. Rest of World Historic Review for Cardiac Rhythm Management Devices by Product Segment – Implantable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)

Table 41. Rest of World 15-Year Perspective for Cardiac Rhythm Management Devices by Product Segment - Percentage Breakdown of Dollar Sales for Implantable Cardioverter Defibrillators, Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) for Years 2003, 2010 & 2017 (includes corresponding Graph/Chart)

Total Companies Profiled: 48 (including Divisions/Subsidiaries - 125)
Region/CountryPlayers
The United States30
Canada
Japan
Europe
France
Germany
The United Kingdom
Italy
Spain
Rest of Europe
Asia-Pacific (Excluding Japan)
Latin America
Africa